AstraZeneca

AstraZeneca and Sun Pharma Expand Access to Hyperkalaemia Treatment with New SZC Brand Partnership in India

18 Nov 2025

1 min read

European Commission Approves AstraZeneca’s Koselugo® for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

European Commission Approves AstraZeneca’s Koselugo® for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

30 Oct 2025

2 min read

FDA Approves TEZSPIRE® (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps, Expanding Its Use Beyond Severe Asthma

FDA Approves TEZSPIRE® (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps, Expanding Its Use Beyond Severe Asthma

18 Oct 2025

3 min read

Read More

Voice Of HealthCare

vohnetwork.com